Identification of Mycobacterium tuberculosis proteases as targets for drug discovery and development
| Reference number | |
| Coordinator | Medivir Aktiebolag |
| Funding from Vinnova | SEK 7 426 125 |
| Project duration | August 2009 - July 2013 |
| Status | Completed |
Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
Identification of Mycobacterium tuberculosis proteases as targets for drug discovery and development
| Reference number | 2009-00134 |
| Coordinator | Medivir Aktiebolag |
| Funding from Vinnova | SEK 7 426 125 |
| Project duration | August 2009 - July 2013 |
| Status | Completed |
Last updated 25 November 2019
Reference number 2009-00134